Socioeconomic Disparities in Intravitreal Injection Use and Anti-VEGF Agent Selection: Aflibercept/Ranibizumab Versus Bevacizumab. - Ko MY; Talebi R; Yu F; Tseng VL; Coleman AL; Hosseini H (Clinical therapeutics, 2025)